Renaissance Technologies - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 152 filers reported holding HERON THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$6,978,300
+104585.0%
1,993,800
-17.1%
0.01%
+20.0%
Q1 2024$6,666
+108.2%
2,406,486
+27.8%
0.01%
+100.0%
Q4 2023$3,202
+967.3%
1,883,300
+546.5%
0.01%
+400.0%
Q3 2023$300
-75.6%
291,300
-72.5%
0.00%
-50.0%
Q2 2023$1,229
-28.7%
1,059,100
-7.2%
0.00%0.0%
Q1 2023$1,723
+111.2%
1,140,836
+249.4%
0.00%
+100.0%
Q4 2022$816
-100.0%
326,500
+100.8%
0.00%
-66.7%
Q1 2021$2,636,000
+31.9%
162,600
+20.6%
0.00%
+50.0%
Q3 2020$1,998,000
-43.4%
134,800
-43.8%
0.00%
-33.3%
Q2 2020$3,527,000
-71.4%
239,800
-77.2%
0.00%
-75.0%
Q1 2020$12,349,000
+190.3%
1,051,892
+481.2%
0.01%
+300.0%
Q4 2019$4,254,000
+134.9%
181,000
+85.8%
0.00%
+50.0%
Q2 2019$1,811,000
-57.3%
97,400
-27.4%
0.00%
-50.0%
Q3 2018$4,244,000
-72.2%
134,100
-65.8%
0.00%
-50.0%
Q2 2018$15,249,000
+956.0%
392,500
+391.9%
0.01%
+300.0%
Q4 2017$1,444,000
-3.7%
79,800
+65.9%
0.00%
-33.3%
Q2 2015$1,499,00048,1000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TANG KEVIN 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders